Lemaitre Vascular (LMAT) Net Margin (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Net Margin data on file, last reported at 23.56% in Q1 2026.

• Net Margin for Q1 2026 came in at 23.56%, up 517.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.03% (down 2379.0% YoY), and the FY2025 annual result was 6.0%, down 2583.0% from the prior year.
• Net Margin advanced to 23.56% in Q1 2026 per LMAT's latest filing, from 88.65% in the prior quarter.
• Over five years, Net Margin peaked at 28.44% in Q3 2025 and troughed at 88.65% in Q4 2025.
• A 5-year average of 11.34% and a median of 16.16% in 2023 frame the typical range for Net Margin.
• On a YoY basis, Net Margin climbed as much as 812 bps in 2025 and fell as far as 10791 bps in 2025.
• A 5-year view of Net Margin shows it stood at 13.3% in 2022, then gained by 10 bps to 14.58% in 2023, then jumped by 32 bps to 19.26% in 2024, then plunged by 560 bps to 88.65% in 2025, then surged by 127 bps to 23.56% in 2026.
• Business Quant data shows LMAT's Net Margin at 23.56% in Q1 2026, 88.65% in Q4 2025, and 28.44% in Q3 2025.